Pricing

Log inSign up

Renalytix

31 people · 0 jobs
‌

Renalytix (LSE: RENX) (NASDAQ: RNLX) is the founder and global leader in the new field of bioprognosis™ for kidney health.

Industries

Biotechnology

Headquarters

New York, United States

Employees

51-200

Links

Org chart

JM
James McCullough
CEO
Collapse
Fergus Fleming
CTO
MD
Michael J. Donovan
Chief Medical Officer
Elise Wilfinger
Chief Strategy & Marketing Officer
Christopher Scott
Chief Operating Officer

Board & advisors

CM
Christopher Mills
Non-Executive Director
EL
Erik Lium
Non-Executive Director
CP
Chirag R. Parikh
Non-Executive Director
Daniel J. Levangie
Non-Executive Director
TS
Timothy J. Scannell
Non-Executive Directors
Catherine Coste
Director

Offices

Similar companies

Sutro Biopharma

3 followers

Active Motif

3 followers

Dyno Therapeutics

4 followers

Janux Therapeutics

1 follower

Eikon Therapeutics

3 followers

Gilead Sciences

171 followers

Regeneron

144 followers

Illumina

81 followers

Agilent Technologies

89 followers

Verily Life Sciences

48 followers

Alexion Pharmaceuticals

49 followers

Explore companies